VISCHER advised ImmunOs Therapeutics AG on all legal issues related to the transaction. ImmunOs Therapeutics AG, a biopharmaceutical company leveraging its unique immune system modulating HLA-based...
You must be a Standard 1 Year member to access this content.
VISCHER acted as legal counsel to OCHSNER SPORT and DOSENBACH. OCHSNER SPORT and DOSENBACH concluded agreements with MIGROS according to which OCHSNER SPORT and DOSENBACH will...
You must be a Standard 1 Year member to access this content.
VISCHER advised Ysios Capital and Kurma Partners. Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised...
You must be a Standard 1 Year member to access this content.
VISCHER advised narrowin GmbH on all aspects on this transaction. The German energy supplier EnBW enters into a partnership with narrowin GmbH, a Swiss cybersecurity start-up....
You must be a Standard 1 Year member to access this content.
